Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation
Acadesine (ACA), a pharmacological activator of AMP-activated protein kinase (AMPK), showed a promising beneficial effect in a mouse model of colitis, indicating this drug as an alternative tool to manage IBDs. However, ACA displays some pharmacodynamic limitations precluding its therapeutical appli...
Main Authors: | Luca Antonioli, Carolina Pellegrini, Matteo Fornai, Laura Benvenuti, Vanessa D’Antongiovanni, Rocchina Colucci, Lorenzo Bertani, Clelia Di Salvo, Giorgia Semeghini, Concettina La Motta, Laura Giusti, Lorenzo Zallocco, Maurizio Ronci, Luca Quattrini, Francesco Angelucci, Vito Coviello, Won-Keun Oh, Quy Thi Kim Ha, Zoltan H. Németh, Gyorgy Haskó, Corrado Blandizzi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/12/6325 |
Similar Items
-
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A<sub>3</sub> Receptor Agonist, in a Rat Model of Colitis
by: Luca Antonioli, et al.
Published: (2020-06-01) -
Perturbed Mitochondrial Dynamics Is a Novel Feature of Colitis That Can Be Targeted to Lessen DiseaseSummary
by: Nicole L. Mancini, et al.
Published: (2020-01-01) -
Pomegranate Mesocarp against Colitis-Induced Visceral Pain in Rats: Effects of a Decoction and Its Fractions
by: Carmen Parisio, et al.
Published: (2020-06-01) -
A Gut-Ex-Vivo System to Study Gut Inflammation Associated to Inflammatory Bowel Disease (IBD)
by: Mara Gagliardi, et al.
Published: (2021-06-01) -
The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia
by: Vanessa D’Antongiovanni, et al.
Published: (2020-07-01)